![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Solabia Pantin Fr, based in France, is a pharmaceutical company.
One of their significant offerings is Chondroitin sulfate sodium, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2000-220 - Rev 02
This TSE Type CEP, issued on July 25, 2012, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2064 associated with this CEP further emphasizes